After a long, strange trip, this CEO is close to taking a psilocybin pill to market

Fecha de publicación: 25 de octubre de 2026, 14:07

A lot is riding on the shoulders of Kabir Nath, the CEO of Compass Pathways. Scott Semler for BI Compass Pathways wants to use psilocybin to help people with treatment-resistant depression. Its psilocybin pill, COMP360, could finally be coming to market as soon as next year. For its CEO, Kabir…